BankInvest
VC Fund
Copenhagen, Denmark
BankInvest is a asset manager and provider of investment funds in the Nordic region with a total asset under management and administration of more than DKK 92 billion.
- Total investments:
- 13
- Last investment:
- Lead investor:
- 15%
Last updated:
For AI agents: llms.txt
Industries BankInvest invests in
ManufacturingSolarHealth CareEnergySoftware
Stages BankInvest invests in
Funding RoundPost-IPO EquitySeries BSeries ASeries C
Countries BankInvest invests in
DenmarkUnited KingdomUnited StatesGermany
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Stefan Ingildsen
|
|||
|
H. Lundbeck
|
|||
Lars Bertram
|
|||
|
Markus Postler
|
|||
Investment Focus
Industry
- Manufacturing 4 (31%)
- Solar 3 (23%)
- Health Care 3 (23%)
- Energy 2 (15%)
- Software 2 (15%)
Stage
- Funding Round 4 (31%)
- Post-IPO Equity 3 (23%)
- Series B 2 (15%)
- Series A 1 (8%)
- Series C 1 (8%)
Country
- Denmark 5 (38%)
- United Kingdom 3 (23%)
- United States 2 (15%)
- Germany 1 (8%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
|
Stefan Ingildsen
Senior Portfolio Manager
|
Senior Portfolio Manager | Total investments: 3 | Find email | |
|
H. Lundbeck
Team Member
|
Team Member | Total investments: 0 | Find email | |
|
Lars Bertram
CEO
|
CEO | Total investments: 2 | Find email | |
|
Markus Postler
Director of Sales and Marketing
|
Director of Sales and Marketing | Total investments: 0 | Find email |
Investments
| Company | Description | Round | Links |
|---|---|---|---|
Donkey Republic
|
Donkey Republic enables cities to create a better quality of life, getting people on two wheels. We provide a flexible, reliable and open bike sharing platform that adjusts to the needs of the city, and integrates to rest of the public transport. We provide bike- and ebike sharing service using virtual or physical docking stations, for both short-and long term rentals. | $11.8M / Post-IPO Equity / Feb 19, 2026 | |
MedTrace Pharma
|
MedTrace develops a hardware platform (MT-100) that automates the production and injection of the gold standard tracer 15O-water into the patient. MedTrace also develops an analytical software platform to interpret the results from the PET scanner.By use of 15O-water, doctors will increase sensitivity in the analysis of the patient while at thesame time increasing patient throughput up to a factor of 4 compared to today's clinical workhorse. | $11.1M / Series F / May 12, 2025 | |
MapsPeople
|
MapsPeople specializes in indoor wayfinding that creates high value for end-users and provides businesses with important insights. With their unique indoor navigation platform (proprietary software) MapsPeople equips users with turn-by-turn navigation and a clear overview of spaces and points of interest. Poor wayfinding leads to confusion,frustration, and time waste, which results in loss of revenue for venue owners and loss of productivity for management. The platform has been developed since 2014 and has now achieved a position as the preferred indoor navigation platform for high-profile logos worldwide. With exponential growth, the company is now the global market leader in this space.The company is focused on the American and European markets and operates from offices in Austin, Texas, Germany, and Denmark. | $1.4M / Post-IPO Equity / Feb 17, 2023 | |
OrderYoyo
|
Our focus is to help take-aways and restaurants make more money. We offer you your OWN platform, which includes: iPhone App, Android App and a Web-based ordering module. Through the app we enable you to communicate directly with your regular customers about great offers and new menus and to receive orders. Use takeaway portals like Just-Eat to getnew customers – and once you’ve got them, convert them to order take-away directly from YOUR ordering platform. | $6M / Post-IPO Equity / Mar 31, 2022 | |
|
MedTrace Pharma
|
MedTrace develops a hardware platform (MT-100) that automates the production and injection of the gold standard tracer 15O-water into the patient. MedTrace also develops an analytical software platform to interpret the results from the PET scanner.By use of 15O-water, doctors will increase sensitivity in the analysis of the patient while at thesame time increasing patient throughput up to a factor of 4 compared to today's clinical workhorse. | May 12, 2021 | |
|
MedTrace Pharma
|
MedTrace develops a hardware platform (MT-100) that automates the production and injection of the gold standard tracer 15O-water into the patient. MedTrace also develops an analytical software platform to interpret the results from the PET scanner.By use of 15O-water, doctors will increase sensitivity in the analysis of the patient while at thesame time increasing patient throughput up to a factor of 4 compared to today's clinical workhorse. | $29.2M / Series B / May 12, 2021 | |
Visiopharm
|
Visiopharm image analysis and stereology software has become the preferred Quantitative Digital Pathology solution for leading biopharmaceutical companies, contract research organizations (CRO), academic medical centers, research institutes, and hospitals all over the world. Recently, Visiopharm has expanded to include ONCOtopix™ Dx a robustsolution for cancer diagnostics with CE-IVD algorithms for the breast panel, integrated LIS driven workflow, and Virtual Double Staining. Their software is featured in over 800 scientific publications, and is compatible with leading slide scanner manufacturers, data management software, and a wide variety of microscopes and cameras.Visiopharm, a privately owned company, was founded in 2001 by the Managing Director, and Chief Executive Officer, Michael Grunkin and the Chief Technical officer, Johan Doré Hansen, who both have a strong scientific and practical background in image analysis.Their company has grown into an international business with over 500 licenses in more than 30 countries. Their growing network of authorized distributors and partners support the growth of Visiopharm solutions on several continents including North America, Europe and Asia. Their headquarters is located in the Medicon Valley of Denmark, with a branch office in the Netherlands, and a North America office in Broomfield, Colorado. | Sep 01, 2020 | |
iosil Energy
|
Iosil Energy Corporation produces "high purity polysilicon," the essential raw material for solar cells. The Corporation was founded in 2007, with its R&D facilities located in the National Institute for Nanotechnology In Edmonton, Alberta.The company has demonstrated its ability to produce high-purity solar grade polysilicon fromthe waste material (or “kerfâ€) created by wafer sawing operations, saving costs. | $13.5M / Private Equity / Mar 17, 2012 | |
Enecsys
|
Enecsys Limited, develops, manufacturers, and markets world-leading, highly reliable, grid-connected solar micro inverters and monitoring systems that offer an outstanding value proposition for solar PV systems. The micro inverter accepts DC power from each solar module and converts it into clean AC power for supply to the electricity grid. Theadvantages of Enecsys solar micro inverters include: maximized energy harvest, improved safety, increased lifetime and reliability, enhanced performance monitoring, and simplified PV array design and installation. The monitoring system tracks, in real-time, the performance of each PV module and transmits the information through a robust built-in wireless communication system that connects to the Internet via a gateway. Headquartered in Cambridge, UK, the company also has sales and support offices in Bad Homburg, Germany; Redwood Shores, California, USA; and Taipei, Taiwan. For more information, please visit www.enecsys.com.. | $9.9M / Series A / Jun 24, 2009 | |
Nujira
|
In the cellular and digital broadcast infrastructure markets, Nujira's High Accuracy Tracking (HATâ„¢) Power Modulators for 3G, evolved 3G, DVB and WiMAX broadband RF power amplifiers enable equipment vendors to design flexible, power-efficient, smaller, cheaper base stations and transmitters to meet the increasingly demanding needs ofoperators and broadcasters worldwide. | $18M / Series C / Sep 15, 2008 | |
| See all 13 investments → | |||
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Recommended lists
SaaS Investors
99,274 investors
Software Investors
50,021 investors
Health Care Investors
43,014 investors
Climate Investors
40,325 investors
Energy Investors
25,111 investors
Manufacturing Investors
24,696 investors
Impact Investors
20,240 investors
Sustainability Investors
20,240 investors
SaaS VC Funds
61,208 investors
FAQ
What does BankInvest invest in?
BankInvest invests primarily in Manufacturing, Solar and Health Care startups, most often at Funding Round and Post-IPO Equity stage. Most of the 13 investments tracked by Shizune back companies in Denmark. The Investment Focus section breaks down every industry, stage and country in the portfolio.
How do I contact BankInvest?
Public channels for BankInvest include LinkedIn, X (Twitter) and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at BankInvest?
The team at BankInvest includes Stefan Ingildsen (Senior Portfolio Manager), H. Lundbeck (Team Member) and Lars Bertram (CEO). The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
